International Stem Cell CORP Cash And Cash Equivalents At Carrying Value

Quick Answer

International Stem Cell CORP reported Cash And Cash Equivalents At Carrying Value of $304.0 thousand for the year ending 2017.

  • International Stem Cell CORP showed an increase of +176.4% in Cash And Cash Equivalents At Carrying Value from 2016 to 2017.
  • This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on April 9, 2018.
  • XBRL data for this metric is available from 2009 to 2017 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2009 to 2017), International Stem Cell CORP's Cash And Cash Equivalents At Carrying Value has declined by 58.2%.
  • Historical annual values: Fiscal year 2017: $304.0 thousand | Fiscal year 2016: $110.0 thousand | Fiscal year 2015: $532.0 thousand | Fiscal year 2014: $1.11 million | Fiscal year 2013: $2.24 million | Fiscal year 2012: $654.0 thousand | Fiscal year 2011: $1.34 million | Fiscal year 2010: $5.78 million | Fiscal year 2009: $727.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: